COST-EFFECTIVENESS ANALYSIS OF HAPLOIDENTICAL VS MATCHED UNRELATED ALLOGENEIC HEMATOPOIETIC STEM CELLS TRANSPLANTATION IN PATIENTS OLDER THAN 55 YEARS

Author(s)

Debals-Gonthier M¹, Siani C², Faucher C³, Touzani R⁴, Lemarie C³, Chabannon C³, Furst S³, Devillier R³, Caymaris L³, Blaise D³, Le Corroller Soriano A⁴
¹Aix-Marseille University, Marseille, France, ²ISPB, Faculte de Pharmacie, Lyon, France, University Lyon 1, University of Lyon, Lyon, France, ³Institut Paoli-Calmettes, Marseille, France, ⁴INSERM, Marseille, France

Due to limited donor availability, high comorbidities and cost issues, allogeneic hematopoietic stem cell transplant is not universally accessible. Haploidentical related donors can be found for almost every patient but no economic evaluation has been previously conducted to compare this alternative strategy to match sibling transplant.

OBJECTIVES: The aim of our study was to conduct a cost-effectiveness analysis of haploidentical vs matched unrelated donnor (MUD) transplant.

METHODS:

RESULTS:

CONCLUSIONS: Our study was associated with a “real world” practice observation, with data offering good external validity characteristics. Among older patients suffering from hematological malignancies, haploidentical transplant is a promising alternative to matched unrelated transplant and first economic arguments supports its diffusion.

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PCN139

Topic

Economic Evaluation

Topic Subcategory

Cost-comparison, Effectiveness, Utility, Benefit Analysis

Disease

Oncology

Explore Related HEOR by Topic

Economic Evaluation

Presentation